Childhood Activities Nutrition and Development Oversight

Launched by NORTHWESTERN UNIVERSITY · Feb 25, 2022

Keywords

ClinConnect Summary

The Childhood Activities Nutrition and Development Oversight trial is a research study aimed at understanding how children develop and how specific health education can help parents or caregivers promote healthy growth in their infants. The study will provide guidance on important topics like sleep, nutrition, building a loving relationship with your baby, and managing screen time. It seeks to find out if these resources make a difference in children's health and development.

To participate, infants must be under 26 weeks old at the time of enrollment, and their parents or guardians need to be willing to provide informed consent and follow the study's procedures. The study is currently looking for families of all backgrounds, and participants will be randomly assigned to either receive the educational resources or be part of a control group. It's important to note that certain health conditions or circumstances may prevent some infants from participating, such as specific medical diagnoses or if a sibling is already enrolled in the study. Overall, this trial offers a chance to learn more about fostering healthy habits in young children!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Parent/guardian(s) must understand and provide informed consent
• • Infant \<26 weeks of age at enrollment
• • Willing to be randomized to either intervention or control
• • In good general health as evidenced by medical history
• • Stated willingness to comply with all study procedures and availability for the duration of the study
• • Child assigned male or female sex at birth
• Exclusion Criteria:
• • Infant completed less than 28 weeks gestation
• • Co-morbid medical diagnoses that would prevent caregivers from initiating solid foods per protocol, such as dysphagia, chronic aspiration, malformations, etc.
• • Co-morbid medical diagnoses that would require specialized diet/nutritional needs, such as congenital heart disease, genetic/metabolic disorders, malignancy, etc.
• • Caregivers who express unwillingness to introduce peanut, milk, egg, or cashew
• • Caregivers who cannot provide informed consent in English or Spanish
• • Parents planning to move away from study sites before child is 12 months of age
• • Investigator or designee considers that the participant or parent/guardian would be unsuitable for inclusion in the study
• • Infant with a sibling enrolled in the study